158 related articles for article (PubMed ID: 8619357)
1. Clinical tolerance and diagnostic efficacy of iobitridol 300 in lower limb angiography.
Stockx L; Wilms G; Baert AL; Terrier F
Acta Radiol Suppl; 1996; 400():72-4. PubMed ID: 8619357
[TBL] [Abstract][Full Text] [Related]
2. Less iodine injected for the same diagnostic performances: comparison of two low-osmolar contrast agents (iobitridol 350 and iopamidol 370) in coronary angiography and ventriculography: a randomized double-blind clinical study.
Velázquez MT; Albarrán A; Hernández F; García Tejada J; Zueco J; Andreu J; De la Torre JM; Figueroa A; Sainz F; Tascón J
Acta Cardiol; 2010 Aug; 65(4):387-94. PubMed ID: 20821930
[TBL] [Abstract][Full Text] [Related]
3. A prospective, randomized trial to determine the early and late reactions after the use of iopamidol 340 (Niopam) and iobitridol 350 (Xenetix) in cardiac catheterization.
Vijayalakshmi K; Williams D; Wright RA; Hall JA; Harcombe AA; Linker NJ; Stewart MJ; Davies A; de Belder MA
J Invasive Cardiol; 2004 Dec; 16(12):707-11. PubMed ID: 15596875
[TBL] [Abstract][Full Text] [Related]
4. Iobitridol 250 vs iohexol 240 in phlebography of th lower limbs. A double-blind clinical trial.
Chagnaud C; Moulin G; Bartoli JM; Rousseau H; Railhac JJ; Lyonnet D
Acta Radiol Suppl; 1996; 400():89-91. PubMed ID: 8619362
[TBL] [Abstract][Full Text] [Related]
5. Clinical tolerance and diagnostic efficacy of iobitridol in contrast-enhanced CT in children.
Smets A; Shaw D
Acta Radiol Suppl; 1996; 400():65-7. PubMed ID: 8619355
[TBL] [Abstract][Full Text] [Related]
6. A double-blind study of iopromide 300 for peripheral arteriography. Results of a multi-institutional comparison of iopromide with iohexol and iopamidol.
Druy EM; Bettmann MA; Jeans W
Invest Radiol; 1994 May; 29 Suppl 1():S102-5; discussion S106. PubMed ID: 8071036
[TBL] [Abstract][Full Text] [Related]
7. Double-blind study of the safety, tolerance, and diagnostic efficacy of iopromide as compared with iopamidol and iohexol in patients requiring aortography and visceral angiography.
Faykus MH; Cope C; Athanasoulis C; Druy EM; Hedgcock M; Miller FJ; Bron K
Invest Radiol; 1994 May; 29 Suppl 1():S98-101; discussion S106. PubMed ID: 8071053
[TBL] [Abstract][Full Text] [Related]
8. In response to: K. Vijayalakshmi, et al, vol. 16, no. 12, pp. 707-711: A prospective, randomized trial to determine the early and late reactions after the use of iopamidol 340 (Niopam) and iobitridol 350 (Xenetix) in cardiac catheterization.
Pinès E; Zamia P; Idée JM
J Invasive Cardiol; 2005 Feb; 17(2):123-4. PubMed ID: 15770762
[No Abstract] [Full Text] [Related]
9. In response to: K. Vijayalakshmi, et al, vol. 16, no. 12, pp. 707-711: A prospective, randomized trial to determine the early and late reactions after the use of iopamidol 340 (Niopam) and iobitridol 350 (Xenetix) in cardiac catheterization.
Gayet JL; Lefevre T
J Invasive Cardiol; 2005 Feb; 17(2):124. PubMed ID: 15770763
[No Abstract] [Full Text] [Related]
10. Clinical experience with iobitridol 250-300 in digital subtraction angiography. Double-blind randomized studies vs. iopromide and iohexol.
Bouard JC; Lyonnet D; Illes JP; Bouard-Monnier C; Rouviere O; Pangaud C
Acta Radiol Suppl; 1996; 400():85-8. PubMed ID: 8619361
[TBL] [Abstract][Full Text] [Related]
11. Safety and efficacy of the new iodinated nonionic low-osmolality contrast medium Iobitridol (Xenetix) in coronary and ventricular angiography.
Lefevre T; Funck F; Aliot E; Ethevenot B
Acta Radiol Suppl; 1996; 400():75-80. PubMed ID: 8619358
[TBL] [Abstract][Full Text] [Related]
12. Safety and efficacy of Xenetix, a new iodinated contrast agent, in pediatric angiocardiography.
Rossignol AM; Lusson JR; Chantepie A; Losay J
Acta Radiol Suppl; 1996; 400():81-4. PubMed ID: 8619360
[TBL] [Abstract][Full Text] [Related]
13. A comparison of iopromide with iopamidol and iohexol for contrast-enhanced computed tomography.
Goldberg SN; Abrahams J; Drayer BP; Golding S; Bernardino M; Brunetti J
Invest Radiol; 1994 May; 29 Suppl 1():S76-83; discussion S93. PubMed ID: 8071050
[TBL] [Abstract][Full Text] [Related]
14. Iobitridol 300 compared to iopromide 300--a double-blind randomized phase-III study of clinical tolerance in total body CT.
Hoogewoud HM; Woessmer B
Acta Radiol Suppl; 1996; 400():62-4. PubMed ID: 8619354
[TBL] [Abstract][Full Text] [Related]
15. [Are nonionic contrast media identical in their tolerability? Results of a double-blind randomized multicenter study with iomeprol and iopromide].
Schmiedel E
Aktuelle Radiol; 1997 Jul; 7(4):183-8. PubMed ID: 9340014
[TBL] [Abstract][Full Text] [Related]
16. Comparison of iopromide with iohexol and iopamidol in coronary arteriography and left ventriculography.
Bergelson B; Bettmann MA; Wexler L; Wilson R; Dyet J
Invest Radiol; 1994 May; 29 Suppl 1():S107-11; discussion S118-9. PubMed ID: 8071037
[TBL] [Abstract][Full Text] [Related]
17. [Tolerability of nonionic contrast media--results of a multicenter double blind study].
Schmiedel E
Aktuelle Radiol; 1992 May; 2(3):148-52. PubMed ID: 1610929
[TBL] [Abstract][Full Text] [Related]
18. A randomised, double-blind trial of iomeprol and iopromide in intravenous excretory urography.
Harding JR; Bertazzoli M; Spinazzi A
Eur J Radiol; 1994 May; 18 Suppl 1():S93-6. PubMed ID: 8020526
[TBL] [Abstract][Full Text] [Related]
19. A double-blind study comparing the efficiency, tolerance and renal effects of iopromide and iopamidol.
Kennedy C; Rickards D; Lee S; Sharp MB; Dawson P
Br J Radiol; 1988 Apr; 61(724):288-93. PubMed ID: 3285943
[TBL] [Abstract][Full Text] [Related]
20. Efficacy and safety of iobitridol versus iohexol for contrast-enhanced CT of the head.
Drouillard J; Froment JC; Frija G; Caille JM; Gandon Y; Clarisse J; Gaston A
Acta Radiol Suppl; 1996; 400():56-61. PubMed ID: 8619353
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]